Turin September Italian and European experiences come across: IBD and beyond

Dimensione: px

Iniziare la visualizzazioe della pagina:

Download "Turin September Italian and European experiences come across: IBD and beyond"

Adelina Beretta
6 anni fa
Visualizzazioni

1 Turin September 2016 Italian and European experiences come across: IBD and beyond

2 Turin September 2016 RATIONALE Le malattie infiammatorie croniche (IBD) non sono solo un problema clinico, ma anche epidemiologico e gestionale che trascende costantemente il campo della semplice Gastroenterologia, richiedendo spesso il coinvolgimento di diverse figure professionali per la gestione delle molteplici problematiche che interessano il paziente. Il meeting internazionale, giunto quest anno alla sua quarta edizione con cadenza biennale, mira ad approfondire molti di questi aspetti coinvolgendo esperti internazionali e platee di specialisti che si dedicano alla gestione di queste malattie in Italia e all estero. Le precedenti edizioni hanno consentito di sviluppare il confronto con il Belgio (2010), la Francia (2012), i Paesi dell Europa Orientale (2014). In questa edizione il confronto avverrà con i colleghi Danesi e Tedeschi. L organizzazione del meeting è volta a favorire, grazie alle numeriche limitate dei partecipanti (120 discenti al massimo), un contatto con i maggiori esperti nazionali e internazionali, anche allo scopo di favorire un attività di networking che possa durare al di fuori ed al di là dell evento stesso. Ci auguriamo di potervi trovare a Torino per il meeting! 2

3 RATIONALE Inflammatory bowel diseases (IBDs) are not only a clinical issue, but also an epidemiological and management issue, which often overcomes the field of Gastroenterology itself. Different health care practicioners with specific profiles are needed to solve different and peculiar problems that patients are facing. This international meeting approaches this year its fourth biennial edition, and it is focused to clarify many of these issues through the involvement of international key opinion leaders and of Italian and international IBD expert physicians. Previous editions were based on the comparison between Italy and Belgium (2010), France (2012) and Easter European Countries (2014). This year the comparison will be with Danish and German colleagues. Based on the limited number of the attendees (120 partecipats maximum), the meeting is aimed to favour occasions of contact and networking with national and international key opinion leaders which may hopefully persist well after the meeting itself. We re looking forward to seeing you in Torino for the meeting! 3

4 Friday September 23 rd 2016 Turin September 2016 First Session IBD Epidemiology: many answers and many open questions Chair: V. Annese Welcome and meeting structure overview R. Rocca IBD epidemiology in Italy: what we know and what we still have to explore A. Kohn IBD epidemiology in Denmark: the Danish IBD registry and results on cancer, mortality and long-term treatment effects issues in IBD E. Langholz Cancer and IBD, an Italian experience L. Biancone How to build-up a solid epidemiologic study: the experience of ECCO-Epicom cohort N. Pedersen General discussion EXTRA CME SESSION LECTURE Efficacy and Safety of Adalimumab in Ulcerative Colitis G. Fiorino Lunch break 4

5 Second Session How deep should we assess IBD? Chair: F. Castiglione The role of a common language in US: the IG-IBD Imaging project in Italy E. Calabrese The role of a common language in endoscopy: the IG-IBD Endo project in Italy M. Comberlato Beyond the scope: endomicroscopy and new endoscopic techniques G.E. Tontini The role of Pathologists in IBD: diagnosis, activity and dysplasia V. Villanacci What can you ask to MRI for inflammatory bowel disease? M. Petracchini General Discussion Coffee Break EXTRA CME SESSION LECTURE Vedolizumab: bridging the future M. Daperno 5

6 Friday September 23 rd 2016 Turin September 2016 Third Session Are we obtaining enough from traditional treatments? Chair: S. Ardizzone Are all mesalamine the same? M. Vecchi The use of ehealth to optimize mesalamine use N. Pedersen Don t forget: why and when an Ophtalmologistist should kick in E. Miserocchi Don t forget: why and when a Rheumatologist should kick in R. Pellerito Don t forget: why and when a Dermatologist should kick in P. Dapavo General discussion 6

7 Saturday September 24 th, 2016 Fourth Session Escalating disease treatments: best strategies for clinical practice Chair: C. Papi What is refractoriness? A user-guide for clinical practice A. Armuzzi Patient profiling for biologic treatments P. Gionchetti Real life experience with s.c. anti-tnf in Italy M. Daperno Real life experience with vedolizumab in Germany D.C. Baumgart Safety of biologics in the year 2016 A. Orlando Danish data on long-term safety issues with anti-tnf agents I. Vind Traditional treatments in the accelerated step-up paradigm in Germany: how use them U. Helwig General discussion Coffee break 7

8 Saturday September 24th, 2016 Turin September 2016 Fifth Session Fertility, pregnancy and miscellanea Chair: R. Rocca Pregnancy and IBD: what do we know today? A. Bortoli Sexuality and fertility in IBD: what should our patients know? M. Julsgaard Is therapeutic drug monitoring becoming a real standard of practice in IBD? R. D Incà IG-IBD registries results: an interim analysis on evolving projects F. Rizzello General Discussion CME testing 8

9 SCIENTIFIC & GENERAL INFORMATION

10 PRESIDENT A.Pera 10 Turin September 2016 SCIENTIFIC SECRETARY R. Rocca M. Daperno SCIENTIFIC COORDINATOR Daperno Marco, Turin (Italy) FACULTY Annese Vito, Florence (Italy) Ardizzone Sandro, Milan (Italy) Armuzzi Alessandro, Rome (Italy) Baumgart Daniel, Berlin (Germany) Biancone Livia, Rome (Italy) Bortoli Aurora, Milan (Italy) Calabrese Emma, Rome (Italy) Castiglione Fabiana, Naples (Italy) Comberlato Michele, Bolzano (Italy) Dapavo Paolo, Turin (Italy) D Incà Renata, Padoa (Italy) Fiorino Gionata, Milan (Italy) Gionchetti Paolo, Bologna (Italy) Helwing Ulf, Kiel (Germany) Julsgaard Mette, Aarhus C (Denmark) Kohn Anna, Rome (Italy) Langholz Ebbe, Hellerup (Denmark) Miserocchi Elisabetta, Milan (Italy) Orlando Ambrogio, Palermo (Italy) Papi Claudio, Rome (Italy) Pedersen Natalia, Herlev (Denmark) Pellerito Raffaele, Turin (Italy) Petracchini Massimo, Turin (Italy) Rizzello Fernando, Bologna (Italy) Rocca Rodolfo, Turin (Italy) Tontini Gian Eugenio, Milan (Italy) Vecchi Maurizio, Milan (Italy) Villanacci Vincenzo, Brescia (Italy) Vind Ida, Hvidovre (Denmark)

GENERAL INFORMATION VENUE NH Santo Stefano Via Porta Palatina, 19 10122 Torino LANGUAGE English is the official language of the Congress.

11 GENERAL INFORMATION VENUE NH Santo Stefano Via Porta Palatina, Torino LANGUAGE English is the official language of the Congress. REGISTRATION Registration Fee 366,00 (VAT 22% included) The Congress registration fee includes the final program, the certificate of attendance, the admission to the scientific sessions, coffee breaks and lunches during breaks CME- CONTINUING MEDICAL EDUCATION The event is part of the 2016 Education Plan by PLS Educational Srl Provider n and it has been accredited by the National Commission for Continuing Medical Education for Medical Specialists in: Gastroenterology, Internal Medicine, General Surgery, Anatomic Pathology, up to a maximum of 120 participants. CME credits will not be issued to more than 120 attendees and to medical professionals specializing in disciplines different from those mentioned above. In order to obtain CME credits, participants are required to attend all CME activities and to pass the post-test by answering at least 75% of the questions correctly. THE EVENT HAS BEEN GRANTED NR. 8.3 CME CREDITS 11

CONTRIBUTION FOR THE CONGRESS REALIZATION CHIESI FARMACEUTICI ORGANIZING

12 UNDER THE AEGIS OF THE SCIENTIFIC SECRETARY WANTS TO EXPRESS ITS HEARTFELT THANKS TO ALL THE SPONSORS FOR THEIR EDUCATIONAL AND NO-CONDITIONING CONTRIBUTION FOR THE CONGRESS REALIZATION CHIESI FARMACEUTICI ORGANIZING SECRETARY PLS Educational Florence, ITALY

Documenti analoghi

Turin September Italian and European experiences come across: IBD and beyond

Turin September Italian and European experiences come across: IBD and beyond Turin 23-24 September 2016 Italian and European experiences come across: IBD and beyond Turin 23-24 September 2016 RATIONALE Le malattie infiammatorie croniche (IBD) non sono solo un problema clinico,